Workforce growth, logistics infrastructure, and education investments are solidifying the area’s position as an up-and-coming cluster in North Carolina.
The alliance expands an existing collaboration with Orphan Therapeutics Accelerator to support cell and gene therapy manufacturing for ultra-rare conditions.
